7.9 C
New York
HomeTop Global News

Top Global News

Sickle cell disease gene therapies Casgevy Lyfgenia insurance cost issues

Blood sample of patient positive tested for sickle cell.Kitsawet Saethao | Istock | Getty ImagesThe approval of two gene therapies to treat sickle cell disease has given hope to patients who suffer from the debilitating disease, which overwhelmingly affects Black people and people...

Sebi orders attachment of bank, demat accounts of DHFL’s ex-promoters in disclosure violation case

Markets regulator Sebi has ordered the attachment of bank accounts as well as shares and mutual fund holdings of Dheeraj Wadhawan and Kapil Wadhawan, the former promoters of Dewan Housing Finance Corp Ltd (DHFL), to recover dues totalling over Rs 22 lakh. This...

Buy this data center firm Vertiv despite its weak guidance

Vertiv Holdings : The data center equipment maker, whose shares have roughly quadrupled over the past year, issued guidance that didn't live up to Wall Street's lofty expectations. However, the stock is now trading well off its lows of the morning. "Data center...

Doctors feel burned out but encouraged by potential of AI, survey says

Suriyapong Thongsawang | Moment | Getty ImagesDoctors in the U.S. are struggling to contend with burnout, staffing shortages and overwhelming administrative workloads, but many are optimistic that artificial intelligence could help to ease these problems, a new survey found. More than 90% of physicians...

Alzheimer’s drug Leqembi launch, Apple Vision Pro nausea

Good afternoon! The launch of the closely watched Alzheimer's drug Leqembi is off to a slow start.Still, demand for the treatment from Biogen and its Japanese partner Eisai is rising.That's the update the two drugmakers gave Wall Street during their latest quarterly earnings calls...

Innovation and M&A to boost these stocks

There's been a lot of chatter about the mental health crisis since the Covid-19 pandemic. Overall, 12 mental health disorders affect 970 million people around the world — or one in eight people, according to the Institute for Health Metrics and Evaluation's Global...